Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Colorectal Cancer
Location: Nashville TN, Louisville KY, Atlanta GA, Ann Arbor MI,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06004245
Phase 1, Recruiting
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Nashville TN, Myrtle Beach SC, Oklahoma City OK,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT03460977
Phase 1, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Aurora CO, Knoxville TN, Carterville IL, Asheville NC,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Location: Nashville TN, Denver CO, Chicago IL, Cleveland OH,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 18+
Code: NCT06566079
Phase 1, Phase 2, Recruiting
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: Nashville TN, St Louis MO, Charlottesville VA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07020221
Phase 1, Phase 2, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
for
Small Cell Lung Cancer, Advanced Solid Malignant Tumor
Location: Nashville TN, Atlanta GA, Canton OH, Detroit MI,
Sponsor: Chipscreen Biosciences, Ltd.
Sex: All
Age: 18+
Code: NCT05271292
Phase 1, Phase 2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy